Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis
J Urol. 2015 Feb;(2):-6., Volume 193, Issue 2, February 2015, Pages 552-553
Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources
Scand J Urol., Volume 49, Issue 1, February 2015, Pages 43-50
Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer
Eur Urol., Volume 67, Issue 6, June 2015, Pages 993-1005
Anxiety in the management of localised prostate cancer by active surveillance
114 Suppl 1:55-61
Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naïve Men?
European Urology, Volume 71, Issue 6, June 2017, Pages 896-903
MRI-targeted or standard biopsy for prostate-cancer diagnosis
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N Engl J Med 2017 Jul 27
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
N Engl J Med. 2017 Jun 04
Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery
Oncotarget. 2017 Mar 14, Volume 8, Issue 11, Pages 18497-18512
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
The Lancet 2017 Feb 25, Volume 389, Issue 10071, Pages 815-822
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries
Sci Rep. 2017 Jan 04, Volume 7, Issue 40003
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
European Urology 2015 Mar 16
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More